Sartorius AG St receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sartorius Pref (SATG_p)
Sartorius Pref stock price live, this page displays ETR SATG_p stock exchange data. View the SATG_p premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sartorius Pref real time stock price chart below.
What Is the Sartorius Pref Stock Price Today?
The Sartorius Pref stock price today is 252.30.
What Is the Stock Symbol for Sartorius Pref?
The stock symbol for Sartorius Pref is "SATG_p."
What Stock Exchange Does Sartorius Pref Trade On?
Sartorius Pref is listed and trades on the Xetra stock exchange.
Is Sartorius Pref a Good Stock to Buy?
Determining whether Sartorius Pref—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SATG_p quote. (ISIN: DE0007165631)
What Is the Sartorius Pref Stock Price Today?
The Sartorius Pref stock price today is 252.30.
What Is the Stock Symbol for Sartorius Pref?
The stock symbol for Sartorius Pref is "SATG_p."
What Stock Exchange Does Sartorius Pref Trade On?
Sartorius Pref is listed and trades on the Xetra stock exchange.
Is Sartorius Pref a Good Stock to Buy?
Determining whether Sartorius Pref—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SATG_p quote. (ISIN: DE0007165631)
252.30
+1.30(+0.52%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
247.00
253.70
52 wk Range
198.50
270.00
SATG_p is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
247.00253.70
52 wk Range
198.50270.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SATG_p Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
273.11
Upside
+8.25%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Sartorius AG St receives Investment Bank Analyst Rating Update- Investing.com
Pro
Sartorius AG St receives Investment Bank Analyst Rating Update- Investing.com
Pro- Sartorius AG St receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Sartorius AG St receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sartorius AG St receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
14 Buy
5 Hold
1 Sell
Ratings:
20 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 273.11
(+8.25% Upside)
Earnings
Latest Release
Jul 23, 2026
EPS / Forecast
1.29 / 1.36
Revenue / Forecast
911.8M / 934.2M
Compare SATG_p to Peers and Sector
Metrics to compare | SATG_p | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSATG_pPeersSector | |
|---|---|---|---|---|
P/E Ratio | 79.4x | 31.5x | −0.4x | |
PEG Ratio | - | −0.22 | 0.00 | |
Price/Book | 5.5x | 2.4x | 2.6x | |
Price / LTM Sales | 4.3x | 3.5x | 3.0x | |
Upside (Analyst Target) | 6.4% | 13.4% | 56.4% | |
Fair Value Upside | Unlock | 9.3% | 7.9% | Unlock |
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sartorius Pref (SATG_p) Stock Price Today?
The Sartorius Pref stock price today is 252.30 EUR.
What Stock Exchange Does Sartorius Pref Trade On?
Sartorius Pref is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for Sartorius Pref?
The stock symbol for Sartorius Pref is "SATG_p."
Does Sartorius Pref Pay Dividends? What’s The Current Dividend Yield?
The Sartorius Pref dividend yield is 0.29%.
What Is the Sartorius Pref Market Cap?
As of today, Sartorius Pref market cap is 13.95B EUR.
When Is the Next Sartorius Pref Earnings Date?
Sartorius Pref will release its next earnings report on Oct 22, 2026.
From a Technical Analysis Perspective, Is SATG_p a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Sartorius Pref Stock Split?
Sartorius Pref has split 1 times.
How Many Employees Does Sartorius Pref Have?
Sartorius Pref has 14279 employees.
What is the current trading status of Sartorius Pref (SATG_p)?
As of Oct 02, 2026, Sartorius Pref (SATG_p) is trading at a price of 252.30 EUR, with a previous close of 251.00 EUR. The stock has fluctuated within a day range of 247.00 EUR to 253.70 EUR, while its 52-week range spans from 198.50 EUR to 270.00 EUR.
What Is Sartorius Pref (SATG_p) Price Target According to Analysts?
The average 12-month price target for Sartorius Pref is 273.11 EUR, with a high estimate of 310 EUR and a low estimate of 190 EUR. 14 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +8.25% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.